Matrubials
PrivateLast Round
Grant
Nov 26, 2025
Total Funding Raised
$411,968
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Matrubials operates in Healthcare & Life Sciences and is based in Davis, California. Its latest recorded funding round was a Grant round in November 2025.
Matrubials is a biotechnology company that develops milk-inspired antimicrobial peptide therapeutics to address antimicrobial resistance and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Fashion & Beauty
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Matrubials Comparables
Compare Matrubials with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vaginal Biome Science | 79% | |
| Gedea Biotech | 78% | |
| Locus Biosciences | 75% |
For institutional investors. Book with your work email.
Matrubials Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 26, 2025 | ||||
| Grant | May 19, 2023 | ||||
| Seed | Aug 5, 2022 | ||||
| Grant | Jul 1, 2022 | ||||
| Grant | May 10, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Matrubials Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
| NIH RADx | Grant |
| Gaingels | Seed |
| The Growth Factory | Seed |
| Bill & Melinda Gates Foundation | Grant |
| The Bill & Melinda Gates Foundation Trust | Grant |
| Y Combinator | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 4, 2025
$50K raised in an angel round.
- Dec 1, 2025
Won Audience Choice Award at NorCal AngelCon.
For institutional investors. Book with your work email.
Matrubials Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Matrubials's valuation, stock price, and market status.
Is Matrubials a public or private company?
Matrubials is a private company.
What is the current stock price of Matrubials?
Matrubials is a private company, so its shares have no public market price. Caplight tracks Matrubials's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Matrubials worth (valuation)?
Valuation information for Matrubials is not publicly available.
Can I buy Matrubials stock?
Matrubials shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Matrubials's last funding round?
Matrubials's most recent funding round was Grant on November 26, 2025.
Who are the main investors in Matrubials?
Key investors in Matrubials include MedStart.
Will Matrubials IPO soon?
No public IPO plans have been announced for Matrubials.
How can I track Matrubials secondary market activity?
Caplight tracks bids, offers, and trades in Matrubials's shares on secondary markets.